BOOK
Oral and Maxillofacial Pain, An Issue of Oral and Maxillofacial Surgery Clinics of North America, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Oral and Maxillofacial Surgery Clinics of North America focuses on Orofacial Pain, and is edited by Dr. Steven Scrivani. Articles will include: Classification and Differential Diagnosis or Orofacial Pain; Psychological Assessment for Chronic Orofacial Pain; Myofascial Pain Disorders; Disorders of the Temporomandibular Joints; Headache and Orofacial Pain; Neuropathic Orofacial Pain; Burning Mouth Syndrome; Orofacial Movement Disorder; Pharmacological Management of Orofacial Pain; Behavioral Medicine for Chronic Orofacial Pain; Injection Therapy for Headache and Facial Pain; Cranial Neuralgias; Intraoral Pain Disorders, and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Oral and Maxillofacial Pain\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface\r | vii | ||
| Classification and Differential Diagnosis of Oral and Maxillofacial Pain\r | vii | ||
| Chronic Orofacial Pain and Behavioral Medicine\r | vii | ||
| A Model for Opioid Risk Stratification: Assessing the Psychosocial Components of Orofacial Pain\r | vii | ||
| Intraoral Pain Disorders\r | vii | ||
| Myofascial Pain: Mechanisms to Management\r | viii | ||
| Internal Derangement of the Temporomandibular Joint: New Perspectives on an Old Problem\r | viii | ||
| Temporomandibular Disorders and Headache\r | viii | ||
| Cranial Neuralgias\r | viii | ||
| Painful Traumatic Trigeminal Neuropathy\r | ix | ||
| Burning Mouth Syndrome\r | ix | ||
| Orofacial Movement Disorders\r | ix | ||
| Medication Treatment Efficacy and Chronic Orofacial Pain\r | ix | ||
| Injection Therapy for Headache and Facial Pain\r | x | ||
| ORAL AND MAXILLOFACIAL SURGERY\rCLINICS OF NORTH AMERICA\r | xi | ||
| FORTHCOMING ISSUES | xi | ||
| November 2016 | xi | ||
| February 2017 | xi | ||
| May 2017 | xi | ||
| RECENT ISSUES | xi | ||
| May 2016 | xi | ||
| February 2016 | xi | ||
| November 2015 | xi | ||
| Preface:\rOral and Maxillofacial Pain | xiii | ||
| Classification and Differential Diagnosis of Oral and Maxillofacial Pain | 233 | ||
| Key points | 233 | ||
| INTRODUCTION | 233 | ||
| DIAGNOSTIC EVALUATION | 234 | ||
| Chief Complaint | 235 | ||
| History of Present Complaint | 235 | ||
| Medical History | 235 | ||
| Physical Examination | 235 | ||
| Muscle examination | 235 | ||
| Temporomandibular joint examination | 236 | ||
| Intraoral examination | 236 | ||
| Neurologic examination | 236 | ||
| Vascular examination | 237 | ||
| Diagnostic Imaging | 237 | ||
| Other Diagnostic Studies | 237 | ||
| Psychosocial Evaluation | 237 | ||
| Summary | 237 | ||
| CLASSIFICATION | 238 | ||
| REFERENCES | 246 | ||
| Chronic Orofacial Pain and Behavioral Medicine | 247 | ||
| Key points | 247 | ||
| INTRODUCTION | 247 | ||
| OROFACIAL PAIN DISORDERS AND SOMATIC FOCUS | 248 | ||
| HISTORICAL REVIEW OF COGNITIVE-BEHAVIORAL THERAPY AND THE THIRD-WAVE DEVELOPMENTS | 249 | ||
| Psychotherapy (Wave 1) | 249 | ||
| The Biopsychosocial Model of Health | 249 | ||
| Cognitive-Behavioral Therapy (Wave 2) | 249 | ||
| Third-Wave Therapies | 250 | ||
| COGNITIVE-BEHAVIORAL THERAPY | 250 | ||
| 15 Styles of Distorted Thinking | 250 | ||
| Filtering | 250 | ||
| Polarized thinking | 250 | ||
| Overgeneralization | 251 | ||
| Mind reading | 251 | ||
| Catastrophizing | 251 | ||
| Personalization | 251 | ||
| Control fallacies | 251 | ||
| Fallacy of fairness | 251 | ||
| Blaming | 251 | ||
| Shoulds | 251 | ||
| Emotional reasoning | 251 | ||
| Fallacy of change | 251 | ||
| Global labeling | 252 | ||
| Being right | 252 | ||
| Heaven's reward fallacy | 252 | ||
| List of Tools and Specific Descriptions | 252 | ||
| Cognitive rehearsal | 252 | ||
| Validity testing | 252 | ||
| Writing in a journal | 252 | ||
| Guided discovery | 252 | ||
| Modeling | 252 | ||
| Homework | 252 | ||
| Aversive conditioning | 252 | ||
| Systematic positive reinforcement | 252 | ||
| THE NEUROSCIENCE OF MINDFULNESS BEHAVIOR | 253 | ||
| Patients with Temporomandibular Disorders and Somatic Arousal | 253 | ||
| Default Mode Network and Chronic Pain | 253 | ||
| Somatic Arousal and Patients with Chronic Pain | 254 | ||
| MINDFULNESS-BASED COGNITIVE THERAPY | 254 | ||
| THE MINDFULNESS-BASED PHYSICAL MEDICINE PROGRAM-SOMATIC QUIETING | 255 | ||
| The Relaxation Response | 256 | ||
| Mindfulness-Based Physical Medicine Protocol | 256 | ||
| Cervical rotation | 257 | ||
| Nose to armpit stretch | 257 | ||
| Ear to shoulder stretch | 258 | ||
| MINDFULNESS-BASED STRESS REDUCTION | 258 | ||
| REFERENCES | 259 | ||
| A Model for Opioid Risk Stratification | 261 | ||
| Key points | 261 | ||
| SUBSTANCE USE DISORDERS | 263 | ||
| A MODEL FOR RISK ASSESSMENT AND PATIENT MANAGEMENT | 264 | ||
| Prescription Monitoring Programs | 265 | ||
| Medical or Dental Records and Cross-Communication with Treating Providers and Others | 266 | ||
| Risk-Screening Questionnaires for Opioid Therapy | 267 | ||
| Counseling the Patient | 268 | ||
| Ask | 268 | ||
| Advise | 269 | ||
| Assess | 269 | ||
| Assist | 269 | ||
| Arrange | 269 | ||
| SPECIAL AT-RISK POPULATIONS | 270 | ||
| The Patient Currently on Opioids and the Patient Abusing Substances | 270 | ||
| SUMMARY | 271 | ||
| REFERENCES | 272 | ||
| Intraoral Pain Disorders | 275 | ||
| Key points | 275 | ||
| INTRODUCTION | 275 | ||
| DENTAL AND PULPAL | 275 | ||
| Caries | 276 | ||
| Exposed Cementum or Dentin | 276 | ||
| Pulpal Disease | 276 | ||
| Cracked Tooth Syndrome | 277 | ||
| PERIODONTAL | 277 | ||
| Gingival/Periodontal Abscess | 277 | ||
| Periapical Inflammatory Lesions | 278 | ||
| Alveolar Osteitis (Dry Socket) | 278 | ||
| Pericoronitis | 279 | ||
| ORAL MUCOSAL PAIN | 279 | ||
| Oral Candidiasis | 279 | ||
| Herpes Simplex Virus | 280 | ||
| Herpes Zoster (Shingles) | 280 | ||
| Necrotizing Periodontal Diseases | 281 | ||
| Recurrent Aphthous Stomatitis | 281 | ||
| Lichen Planus | 282 | ||
| Vesiculobullous Diseases | 282 | ||
| Squamous Cell Carcinoma | 282 | ||
| Oral Mucositis Related to Cancer Therapy | 283 | ||
| Immunocompromised States (Transplantation Medicine, Human Immunodeficiency Virus) | 283 | ||
| BONE | 284 | ||
| Osteomyelitis | 284 | ||
| Osteonecrosis | 284 | ||
| Maxillary Sinusitis | 284 | ||
| SALIVARY GLAND ABNORMALITIES | 285 | ||
| Oral Sialoliths | 285 | ||
| Bacterial Sialadenitis | 285 | ||
| Mumps | 286 | ||
| Sjögren’s Syndrome | 286 | ||
| Salivary Gland Neoplasms | 286 | ||
| REFERENCES | 287 | ||
| Myofascial Pain | 289 | ||
| Key points | 289 | ||
| INTRODUCTION | 289 | ||
| Most Common Chronic Pain Conditions | 290 | ||
| CLINICAL PRESENTATION | 290 | ||
| Clinical Characteristics | 290 | ||
| Association with Other Pain Conditions | 292 | ||
| Relationship to Other Muscle Pain Disorders | 293 | ||
| Myositis | 293 | ||
| Muscle spasm | 293 | ||
| Muscle contracture | 293 | ||
| Fibromyalgia | 293 | ||
| Examination Findings | 293 | ||
| Pain Symptoms | 295 | ||
| Contributing Factors | 295 | ||
| CAUSE AND PATHOPHYSIOLOGY | 296 | ||
| Peripheral and Central Sensitization | 296 | ||
| Peripheral Changes | 296 | ||
| Injury to Muscle Fiber Type I | 297 | ||
| Metabolic Distress at the Motor End Plates | 297 | ||
| Activation of Muscle Nociceptors | 297 | ||
| Central Nervous System Changes | 299 | ||
| Central Biasing of Nociceptive Input | 299 | ||
| EVIDENCE-BASED MANAGEMENT | 299 | ||
| Determine a Complete Problem List | 300 | ||
| Match the Complexity of Management to the Complexity of the Patient | 300 | ||
| Transformative Care Model | 300 | ||
| The Health Care Provider as an Agent of Change | 302 | ||
| Muscle exercises | 302 | ||
| Muscle treatments | 303 | ||
| Intraoral appliance therapy | 304 | ||
| Pharmacotherapy | 304 | ||
| Training to reduce risk factors | 305 | ||
| Interdisciplinary team management | 305 | ||
| SUMMARY | 307 | ||
| REFERENCES | 307 | ||
| Internal Derangement of the Temporomandibular Joint | 313 | ||
| Key points | 313 | ||
| INTRODUCTION | 313 | ||
| CURRENT CLASSIFICATION SYSTEMS FOR TEMPOROMANDIBULAR JOINT DISORDERS | 314 | ||
| INTERNAL DERANGEMENT OF THE TEMPOROMANDIBULAR JOINT: DEFINITION FROM AN ORTHOPAEDIC PERSPECTIVE | 316 | ||
| IS INTERNAL DERANGEMENT A DISEASE? | 316 | ||
| DOES INTERNAL DERANGEMENT REQUIRE TREATMENT? | 317 | ||
| Historical Perspectives | 317 | ||
| Internal Derangement Treatment: Clinical Research Results | 318 | ||
| Does Any Surgical Procedure Reposition and Maintain a Normal Disc Position? | 319 | ||
| MANAGEMENT OF TEMPOROMANDIBULAR JOINT DISORDER BASED ON DISEASE CAUSE: NEW PERSPECTIVES ON INTERNAL DERANGEMENT AS A SIGN O ... | 320 | ||
| Inflammatory/Degenerative Arthropathy: Pathogenesis | 320 | ||
| Treatment of Inflammatory/Degenerative Arthropathy | 323 | ||
| Systemic Arthropathy: Systemic Disorders Causing Temporomandibular Joint Disease | 325 | ||
| Localized Atypical Arthropathy: Intra-Articular Temporomandibular Joint Disorder that Is Atypical and Not Caused by Joint O ... | 326 | ||
| False Arthropathy | 327 | ||
| False Arthropathy Caused by Neoplasia | 328 | ||
| How Common Is Each Etiologic Category in the Classification of Arthropathies of the Temporomandibular Joint? | 329 | ||
| SUMMARY: ETIOLOGIC CLASSIFICATION OF TEMPOROMANDIBULAR JOINT DISORDERS | 330 | ||
| REFERENCES | 330 | ||
| Temporomandibular Disorders and Headache | 335 | ||
| Key points | 335 | ||
| INTRODUCTION | 335 | ||
| EPIDEMIOLOGY OF HEADACHE AND TEMPOROMANDIBULAR DISORDERS COMORBIDITY | 336 | ||
| THE PATHOPHYSIOLOGY RELATIONSHIP OF MIGRAINES AND TEMPOROMANDIBULAR DISORDERS | 337 | ||
| TEMPOROMANDIBULAR JOINT STRUCTURE AND FUNCTION | 337 | ||
| INFLAMMATORY JOINT DISORDERS | 338 | ||
| MUSCULAR PAIN | 338 | ||
| MANAGEMENT | 339 | ||
| Treating Headache by Targeting Temporomandibular Disorders | 339 | ||
| Nonsurgical Temporomandibular Disorder Treatment | 340 | ||
| Patient Education | 340 | ||
| Self-care | 340 | ||
| PHYSICAL THERAPY | 340 | ||
| ORTHOPEDIC JAW APPLIANCES (SPLINTS) | 341 | ||
| BEHAVIORAL INTERVENTIONS | 341 | ||
| PHARMACOTHERAPY | 341 | ||
| Nonsteroidal Antiinflammatory Drugs and Corticosteroids | 341 | ||
| Muscle Relaxants | 342 | ||
| Local Anesthetics | 342 | ||
| Botulinum Toxin | 342 | ||
| COMBINATION OF MULTIPLE THERAPIES | 342 | ||
| SURGICAL TREATMENT | 342 | ||
| TEMPOROMANDIBULAR DISORDER TREATMENTS NOT PROVEN HELPFUL OR EFFECTIVE | 342 | ||
| Occlusal Adjustment in Temporomandibular Disorders and Headache | 343 | ||
| Splint Therapy in Temporomandibular Disorders and Headache | 343 | ||
| SUMMARY | 344 | ||
| REFERENCES | 344 | ||
| Cranial Neuralgias | 351 | ||
| Key points | 351 | ||
| INTRODUCTION | 351 | ||
| CLASSICAL TRIGEMINAL NEURALGIA | 351 | ||
| History | 351 | ||
| Epidemiology | 353 | ||
| Cause and Pathophysiology | 353 | ||
| THE COMPRESSION THEORY | 354 | ||
| PROBLEMS WITH CURRENT THEORIES | 355 | ||
| THERE IS NO OBJECTIVE TEST FOR TRIGEMINAL NEURALGIA | 355 | ||
| TRIGEMINAL NEURALGIA PATIENTS HAVE NO CLINICAL SENSORY ABNORMALITY | 356 | ||
| TRIGEMINAL COMPRESSION DOES NOT PRODUCE TRIGEMINAL NEURALGIA IN ANIMALS | 356 | ||
| SYMPTOMS AND SIGNS | 356 | ||
| COMMENTS ON THE SWEET CRITERIA | 357 | ||
| THE PAIN IN TRIGEMINAL NEURALGIA IS PAROXYSMAL | 358 | ||
| THE PAIN IN TRIGEMINAL NEURALGIA MAY BE PROVOKED BY LIGHT TOUCH TO THE FACE | 358 | ||
| THE PAIN IN TRIGEMINAL NEURALGIA IS CONFINED TO THE TRIGEMINAL ZONE | 359 | ||
| THE PAIN IN TRIGEMINAL NEURALGIA IS UNILATERAL | 359 | ||
| THE CLINICAL SENSORY EXAMINATION IS NORMAL IN TRIGEMINAL NEURALGIA | 359 | ||
| DIFFERENTIAL DIAGNOSIS | 359 | ||
| TREATMENT | 360 | ||
| Medication Treatment | 360 | ||
| Treatment of Acute Attacks | 361 | ||
| Nerve and Neurolytic Blockade Treatment | 361 | ||
| Surgical Treatment | 362 | ||
| SECONDARY TRIGEMINAL NEURALGIA (PAINFUL TRIGEMINAL NEUROPATHY) | 363 | ||
| OTHER CRANIAL NEURALGIAS | 364 | ||
| OTHER TRIGEMINAL BRANCH NEURALGIAS | 364 | ||
| ANESTHESIA DOLOROSA | 365 | ||
| SUMMARY | 365 | ||
| REFERENCES | 365 | ||
| Burning Mouth Syndrome | 381 | ||
| Key points | 381 | ||
| INTRODUCTION | 381 | ||
| EPIDEMIOLOGY | 382 | ||
| DIAGNOSTIC CRITERIA | 382 | ||
| CLASSIFICATION | 382 | ||
| CLINICAL SIGNS AND SYMPTOMS | 384 | ||
| CAUSE | 384 | ||
| Local Factors | 385 | ||
| Systemic Factors | 385 | ||
| Psychological Factors | 385 | ||
| ASSOCIATED FEATURES | 386 | ||
| Saliva | 386 | ||
| Taste | 386 | ||
| Psychosocial Comorbidities | 386 | ||
| PATHOPHYSIOLOGIC THEORIES | 386 | ||
| Taste and Sensory System Interactions | 386 | ||
| Hormonal Alterations | 387 | ||
| Neuropathic Consideration | 387 | ||
| Peripheral small fiber neuropathy | 387 | ||
| Nociceptive channels and neuropeptides | 387 | ||
| Subclinical trigeminal neuralgia | 388 | ||
| Central pain related to deficient dopaminergic inhibition | 388 | ||
| Autoimmune disorder (lichen planus) | 388 | ||
| DIAGNOSIS | 389 | ||
| MANAGEMENT | 389 | ||
| Behavioral Strategies | 389 | ||
| Topical Therapies | 391 | ||
| Systemic Therapies | 391 | ||
| SUMMARY | 391 | ||
| REFERENCES | 391 | ||
| Medication Treatment Efficacy and Chronic Orofacial Pain | 409 | ||
| Key points | 409 | ||
| CHRONIC OROFACIAL PAIN DISEASES AND PHARMACOLOGIC TREATMENT | 409 | ||
| MEDICATIONS FOR TRIGEMINAL NEUROPATHIC PAIN | 410 | ||
| Topical Medicines for Trigeminal Neuropathic Pain | 410 | ||
| Gabapentinoids and Serotonin-Norepinephrine Reuptake Inhibitors Used to Treat Trigeminal Neuropathic Pain | 411 | ||
| Tricyclic Antidepressants for Trigeminal Neuropathic Pain | 412 | ||
| Opioids for Trigeminal Neuropathic Pain | 412 | ||
| MEDICATIONS FOR CHRONIC DAILY HEADACHES | 413 | ||
| Is Naproxen a Good Medication for Treating Episodic Migraine? | 413 | ||
| How Effective Are Preventive Medications for Chronic Migraine? | 413 | ||
| Use of an N-methyl-d-aspartate Receptor Blocking Agent for Chronic Migraines | 414 | ||
| Do Chronic Migraine Patients Take Their Medications as Prescribed? | 414 | ||
| Opioids for Chronic Migraine and Chronic Daily Headache | 415 | ||
| MEDICATIONS FOR CHRONIC MYOFASCIAL PAIN/FIBROMYALGIA | 415 | ||
| Efficacy of Medications to Treat Fibromyalgia | 415 | ||
| Effective Dose and Cost-Benefit of Pregabalin for Fibromyalgia | 416 | ||
| Behavioral Methods Versus Medication in the Treatment of Fibromyalgia | 416 | ||
| Opioids for Fibromyalgia? | 416 | ||
| MEDICATIONS FOR TEMPOROMANDIBULAR ARTHRITIS | 417 | ||
| Nonsteroidal Anti-inflammatory Drugs for Temporomandibular Osteoarthritis | 417 | ||
| Temporomandibular Joint Corticosteroid Injections | 417 | ||
| Anticytokine Therapy for Rheumatoid Arthritis | 418 | ||
| Opioids for Arthritis | 418 | ||
| SUMMARY REGARDING MEDICATIONS FOR CHRONIC OROFACIAL PAIN | 419 | ||
| Neuropathic Pain | 419 | ||
| Chronic Daily Headache | 419 | ||
| Fibromyalgia and Widespread Myofascial Pain | 419 | ||
| Osteoarthritis, Rheumatoid Arthritis, and Juvenile Idiopathic Arthritis | 419 | ||
| REFERENCES | 419 | ||
| Injection Therapy for Headache and Facial Pain | 423 | ||
| Key points | 423 | ||
| INTRODUCTION | 423 | ||
| CLINICAL CONDITIONS TREATED WITH INJECTION THERAPY | 424 | ||
| OVERVIEW OF PHARMACOLOGY | 424 | ||
| MECHANISMS OF NERVE BLOCK EFFECTS IN PRIMARY HEADACHE AND FACIAL PAIN DISORDERS | 424 | ||
| CONTRAINDICATIONS TO PERIPHERAL NERVE BLOCKADE | 425 | ||
| PROCEDURAL TECHNIQUE FOR NERVE BLOCKS | 425 | ||
| Preparation and Patient Positioning | 425 | ||
| Surgical Approach | 425 | ||
| Procedure | 425 | ||
| Immediate postoperative care | 426 | ||
| Patient care postprocedure | 426 | ||
| Possible Complications and Management | 426 | ||
| Mechanical nerve trauma | 426 | ||
| Systemic side effects | 426 | ||
| Other complications | 426 | ||
| SPECIFIC NERVE BLOCKS: TECHNIQUES AND CLINICAL RESULTS IN THE LITERATURE | 426 | ||
| Greater Occipital Nerve Block | 426 | ||
| Anatomy and surgical approach | 426 | ||
| Index | 435 |